Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:psychotherapy
|
| gptkbp:alsoKnownAs |
ART
antiretroviral therapy |
| gptkbp:canBe |
gptkb:pre-exposure_prophylaxis_(PrEP)
post-exposure prophylaxis oral medication injectable medication |
| gptkbp:cause |
drug interactions
drug resistance if not adhered to |
| gptkbp:combines |
other supportive treatments
|
| gptkbp:component |
antiretroviral drugs
|
| gptkbp:contraindication |
drug resistance
severe allergy to components |
| gptkbp:drugClass |
gptkb:NNRTIs
gptkb:NRTIs gptkb:integrase_inhibitors entry inhibitors protease inhibitors |
| gptkbp:goal |
reduce HIV transmission
restore immune function suppress HIV viral load |
| gptkbp:hasApprovedDrug |
zidovudine (AZT)
|
| https://www.w3.org/2000/01/rdf-schema#label |
HIV therapy
|
| gptkbp:improves |
immune system function
life expectancy of HIV patients quality of life for HIV patients |
| gptkbp:introducedIn |
mid-1990s
|
| gptkbp:monitors |
HIV viral load
CD4 count drug resistance testing |
| gptkbp:notACureFor |
gptkb:HIV
|
| gptkbp:recommendation |
gptkb:Centers_for_Disease_Control_and_Prevention
gptkb:World_Health_Organization all people living with HIV |
| gptkbp:reduces |
mother-to-child transmission of HIV
risk of AIDS risk of opportunistic infections |
| gptkbp:requires |
lifelong adherence
personalized regimen selection regular medical follow-up |
| gptkbp:sideEffect |
nausea
diarrhea liver toxicity lipodystrophy kidney toxicity |
| gptkbp:standardRegimen |
combination of at least three drugs
|
| gptkbp:treatment |
HIV infection
|
| gptkbp:bfsParent |
gptkb:INTERfering_and_Co-Evolving_Prevention_and_Therapy_(INTERCEPT)
|
| gptkbp:bfsLayer |
7
|